Reducing PHGDH expression impairs the proliferation in amplified cell, whereas overexpression of PHGDH in human breast cancer contributed to carcinogenesis by facilitating glycolytic pathway to serine biosynthetic pathway [24]. The gene discussed is PHGDH; the disease is breast carcinoma.